Conference Coverage

VIDEO: Isotretinoin revisited: the good, the bad, the latest


 

AT THE CARIBBEAN DERMATOLOGY SYMPOSIUM

GRAND CAYMAN – More than 30 years after isotretinoin became available for the treatment of acne, what are some of the tropes that still hold true? And what misperceptions persist? In a video interview, Dr. Julie C. Harper, a private practitioner in Birmingham, Ala., shares the most up-to-date evidence for and against the drug’s use in patients with acne, including a look at the risk for depression and inflammatory bowel disease, among other tips for prescribing this drug in practice. She was interviewed at the Caribbean Dermatology Symposium provided by Global Academy for Medical Education.

Global Academy and this news organization are owned by the same parent company.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

VIDEO: New diagnostic, treatment methods for fungal infections
MDedge Dermatology
Step therapy and biologics: An easier road ahead?
MDedge Dermatology
Studies backed propranolol in treating infantile hemangioma
MDedge Dermatology
VIDEO: Prophylaxis for atopic dermatitis
MDedge Dermatology
VIDEO: N-acetylcysteine for ichthyosis, OCD behaviors
MDedge Dermatology
VIDEO: Ken Gordon’s pro tips on using biologics in psoriasis
MDedge Dermatology
VIDEO: Addressing rosacea comorbidities and their role in flushing
MDedge Dermatology
Simple points about sunscreen products can address confusion over these products
MDedge Dermatology
Organ transplant recipients face increased risk of BCC
MDedge Dermatology
Axis I psychiatric disorders high in skin-restricted lupus patients
MDedge Dermatology